Evidence map›Paper›PMID 30104706›Full record

ArticleScientific reports2018

Differential expression of miRNA199b-5p as a novel biomarker for sporadic and hereditary parathyroid tumors.

Sena Hwang, Jong Ju Jeong, Se Hoon Kim, Yoon Jung Chung, Sun Yong Song, Yang Jong Lee, Yumie Rhee

Open access · goldAbstract readEvaluation Study
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Serums miR-24-3p and miR-1301-3p as Potential Biomarkers in MEN1 Syndrome.International journal of molecular sciences · 2025
    Article
  2. Article
  3. Review
  4. Review
  5. Are Non-Coding RNAs Useful Biomarkers in Parathyroid Tumorigenesis?International journal of molecular sciences · 2021
    Review
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Sena HwangDepartment of Internal Medicine, CHA University School of Medicine, Chaum Life Center, Seoul, Korea.
Jong Ju JeongDepartment of Surgery, Yonsei University College of Medicine, Seoul, Korea.ORCID 0000-0002-4155-6035
Se Hoon KimDepartment of Pathology, Yonsei University College of Medicine, Seoul, Korea.ORCID 0000-0001-7516-7372
Yoon Jung ChungBrain Korea 21 Project for Medical Science, Yonsei University College of Medicine, Seoul, Korea.
Sun Yong SongDepartment of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.
Yang Jong LeeEndocrinology, Institute of Endocrine Research, Yonsei University College of Medicine, Seoul, Korea.
Yumie RheeDepartment of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea. yumie@yuhs.ac.ORCID 0000-0003-4227-5638
Yonsei University · KRCHA University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

MicroRNAs (miRNAs) are dysregulated in many tumors; however, miRNA regulation in parathyroid tumors remains poorly understood. To identify differentially expressed miRNAs between sporadic and hereditary parathyroid tumors and to analyze their correlation with clinicopathological features, a microarray containing 887 miRNAs was performed; then, the differentially expressed miRNAs were validated by qRT-PCR using 25 sporadic and 12 hereditary parathyroid tumors and 24 normal parathyroid tissue samples. A receiver operating characteristic curve (ROC) analysis was applied to evaluate the utility of the miRNAs for distinguishing parathyroid tumor types. Compared to the miRNAs in the normal parathyroid tissues, 10 miRNAs were differentially expressed between the sporadic and hereditary parathyroid tumors. Seven of these miRNAs (let-7i, miR-365, miR-125a-3p, miR-125a-5p, miR-142-3p, miR-193b, and miR-199b-5p) were validated in the parathyroid tumor samples. Among these miRNAs, only miR-199b-5p was differentially expressed (P < 0.001); miR-199b-5p was significantly downregulated and negatively associated with PTH levels (γ = -0.579, P = 0.002) in the sporadic tumors but was upregulated in the hereditary tumors. This miRNA showed 67% sensitivity and 100% specificity for distinguishing sporadic and hereditary parathyroid tumors. These results reveal altered expression of a miRNA between sporadic and hereditary parathyroid tumors and the potential role of miR-199b-5p as a novel biomarker for distinguishing these two types of parathyroid tumors.

Indexed as

AdultAgedBiomarkers, TumorBiopsyDown-RegulationFemaleGene Expression ProfilingGene Expression Regulation, NeoplasticHumansMaleMicroRNAsMiddle AgedNeoplastic Syndromes, HereditaryOligonucleotide Array Sequence AnalysisParathyroid GlandsParathyroid HormoneBiomarkers, TumorMicroRNAsmirn199 microRNA, humanParathyroid Hormone

Identifiers

PMID30104706
PMCPMC6089933
OpenAlexW2887621237

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.